Sodium Chloride 0.9% Intravenous Infusion
Sponsors
Viridian Therapeutics Inc., Ziekenhuis Oost Limburg, Astellas Pharma Global Development Inc.
Conditions
Gastric AdenocarcinomaGastric CancerGastroesophageal Junction AdenocarcinomaMajor surgery: laparoscopic colorectal surgeryMajor surgery: minimal invasive valve repair or replacement surgeryMajor surgery: off pump coronary bypass surgeryMajor surgery: on pump coronary bypass surgeryMajor surgery: peripheral vascular surgery (femoral popliteal bypass
Phase 3
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal studies
CompletedCTIS2023-507350-33-00
Start: 2024-06-25End: 2025-06-04Target: 76Updated: 2025-05-16
A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination with Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-positive
RecruitingCTIS2024-519773-19-00
Start: 2025-07-31Target: 201Updated: 2026-01-26
Phase 4
The effect of nocturnal dexmedetomidine on postoperative sleep quality and fatigue after major surgery in elderly patients: DEXSLEEP study
RecruitingCTIS2023-510403-22-00
Start: 2024-06-03Target: 102Updated: 2024-04-02
The effect of corticosteroids on early recovery after major surgery in eldery patients: CORTERAS study
Not yet recruitingCTIS2024-517602-28-00
Target: 674Updated: 2024-10-22